Trial Outcomes & Findings for Building Recovery By Improving Goals, Habits, and Thoughts (NCT NCT01191788)

NCT ID: NCT01191788

Last Updated: 2022-10-18

Results Overview

The Beck Depression Inventory II (BDI-II) is a 21 question, self-administered measure of depressive symptoms. Scores range from 0 - 63, with higher scores indicating more severe depressive symptoms.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

299 participants

Primary outcome timeframe

3 Months Post Treatment

Results posted on

2022-10-18

Participant Flow

Participant milestones

Participant milestones
Measure
Group CBT
Clients received up to 16 sessions of group CBT for depression
Comparison
Treatment as Usual comparison condition
Overall Study
STARTED
140
159
Overall Study
COMPLETED
119
137
Overall Study
NOT COMPLETED
21
22

Reasons for withdrawal

Reasons for withdrawal
Measure
Group CBT
Clients received up to 16 sessions of group CBT for depression
Comparison
Treatment as Usual comparison condition
Overall Study
Lost to Follow-up
21
22

Baseline Characteristics

Building Recovery By Improving Goals, Habits, and Thoughts

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Group CBT
n=140 Participants
Clients received up to 16 sessions of group CBT for depression
Comparison
n=159 Participants
Treatment as Usual comparison condition
Total
n=299 Participants
Total of all reporting groups
Age, Categorical
<=18 years
1 Participants
n=5 Participants
0 Participants
n=7 Participants
1 Participants
n=5 Participants
Age, Categorical
Between 18 and 65 years
139 Participants
n=5 Participants
159 Participants
n=7 Participants
298 Participants
n=5 Participants
Age, Categorical
>=65 years
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Age, Continuous
35.31 years
STANDARD_DEVIATION 10.08 • n=5 Participants
37.04 years
STANDARD_DEVIATION 10.53 • n=7 Participants
36.23 years
STANDARD_DEVIATION 10.34 • n=5 Participants
Sex: Female, Male
Female
70 Participants
n=5 Participants
74 Participants
n=7 Participants
144 Participants
n=5 Participants
Sex: Female, Male
Male
70 Participants
n=5 Participants
85 Participants
n=7 Participants
155 Participants
n=5 Participants
Region of Enrollment
United States
140 participants
n=5 Participants
159 participants
n=7 Participants
299 participants
n=5 Participants

PRIMARY outcome

Timeframe: 3 Months Post Treatment

The Beck Depression Inventory II (BDI-II) is a 21 question, self-administered measure of depressive symptoms. Scores range from 0 - 63, with higher scores indicating more severe depressive symptoms.

Outcome measures

Outcome measures
Measure
Group CBT
n=120 Participants
Usual care + BRIGHT intervention. The BRIGHT intervention included 16 two-hour group sessions of CBT for depression.
Comparison
n=140 Participants
Usual care
Depressive Symptoms as Measured by the Beck Depression Inventory II
14.83 BDI-II score
Standard Deviation 11.23
21.82 BDI-II score
Standard Deviation 12.74

SECONDARY outcome

Timeframe: 3 Months Post Treatment

The SF-12 is a 12 question, self-administered measure of general health functioning. The SF-12 outputs a mental health summary score (MCS), which ranges from 0 to 100, with higher scores indicating better mental health functioning. MCS scores are standardized such that mean = 50 and SD = 10 in the general U.S. population.

Outcome measures

Outcome measures
Measure
Group CBT
n=120 Participants
Usual care + BRIGHT intervention. The BRIGHT intervention included 16 two-hour group sessions of CBT for depression.
Comparison
n=140 Participants
Usual care
Mental Health Functioning as Measured by SF-12 MCS.
44.71 SF-12 score
Standard Deviation 11.34
38.44 SF-12 score
Standard Deviation 11.89

Adverse Events

Group CBT

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Comparison

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Katherine Watkins

RAND Corporation

Phone: (310) 393-0411

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place